Public consultation open for AGENAS’ latest Med-Tech assessments

11

Jun 2018

On 11th May, the Italian Ministry of Health announced from its website that five new HTA documents are available for public consultation:

  • Transapical implantation of artificial chordae in patients with primary mitral regurgitation (Horizon Scanning Report No. 21)
  • Electrode catheters with gold tip for radiofrequency ablation in cardiac arrhythmias (Horizon Scanning Report No. 22)
  • Epicardial clip for the left atrial appendage closure (Rapid HTA Report)
  • Flash glucose monitoring systems therapy for diabetes subjects in insulin therapy (Rapid HTA Report)
  • Transcatheter aortic valve implantation (TAVI) in patients at intermediate surgical risk (Rapid HTA Report)

All five assessments were completed in February 2018 by authoring teams led by AGENAS and are written in English. Through the public consultation process, the Ministry aims to collect comments from all relevant stakeholders. The comments will be analyzed by the authoring teams, which will proceed with related amendments of the text. Final versions will be published on the MoH website after that.

The public consultation will be open for 60 days (10th July 2018 is the deadline for comments submission). Comments can be submitted in English using the specific form available on the webpage.

See the page with links at the five full-text documents in English here.

Subscribe to our newsletter delivered every second week not to miss important reimbursement information.

The latest related news

24

Mar 2022

The HTA body of the Tuscany Regional Healthcare issues two types of documents: HTA forms and motivational forms. With a regional decree 2472 of February 10, 2022, Tuscany Regional Healthcare has published assessments of five medical devices of various therapeutic areas, such as cardiovascular and peripheral vascular areas.

Read more

16

Mar 2022

In February 2022, Swedish Medical Technologies Product (MTP) Council issued an updated recommendation on FreeStyle Libre for continuous glucose monitoring in type 2 diabetes (T2D). The initial recommendations were published by NT Council in 2018 and updated by MTP Council in 2020 to include FreeStyle Libre 2. In the 2022 update, MTP Council decreased the Hba1c limit from 70 to 60 mmol/mol and added a statement on lifestyle changes and treatment optimization with non-insulin antidiabetic drugs.

Read more

15

Mar 2022

The Belgian Health Care Knowledge Center (KCE) initiated a study aimed at defining a clear and transparent procedure for the evaluation of digital health technologies in Belgium.

Read more

11

Mar 2022

On February 07, 2022, the Dental and Pharmaceutical Benefits Agency has announced the withdrawal of the assessments of the PhysioMem PM 100 and CardioMem CM 100 XT and the finalization of the assessments of the Zenicor ECG, Coala Heart Monitor Pro, and KardiaMobile. For the conducted assessments, it was outlined that the portable devices provide more limited information than standard ECG measurements; therefore, it was mainly estimated for atrial fibrillation.

Read more

10

Mar 2022

In February 2022, the Finnish Coordinating Center for Health Technology Assessment announced the release of the seven accomplished rapid hospital assessments performed by the Helsinki, Tampere, and Oulu University Hospital. The accomplished rapid HTAs concern the diagnostic imaging, e-Health, endocrine, endoscopy, men’s health, neuromodulation technology groups.

Read more